[HTML][HTML] CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

…, EM Kugler, AE Baxter, O Oniyide, RS Agyekum… - Nature medicine, 2021 - nature.com
Patients with cancer have high mortality from coronavirus disease 2019 (COVID-19), and
the immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 …

Comprehensive mapping of immune perturbations associated with severe COVID-19

…, CAG Ittner, AR Weisman, RS Agyekum… - Science …, 2020 - science.org
Although critical illness has been associated with SARS-CoV-2–induced hyperinflammation,
the immune correlates of severe COVID-19 remain unclear. Here, we comprehensively …

[HTML][HTML] Association of vancomycin plus piperacillin–tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study

…, TG Dunn, AR Weisman, O Oniyide, RS Agyekum… - Intensive Care …, 2022 - Springer
Purpose Although dozens of studies have associated vancomycin + piperacillin–tazobactam
with increased acute kidney injury (AKI) risk, it is unclear whether the association …

[HTML][HTML] CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer

…, EM Kugler, AE Baxter, O Oniyide, RS Agyekum… - Research …, 2021 - ncbi.nlm.nih.gov
Cancer patients have increased morbidity and mortality from Coronavirus Disease 2019 (COVID-19),
but the underlying immune mechanisms are unknown. In a cohort of 100 cancer …

[HTML][HTML] Validating a proteomic signature of severe COVID-19

…, CAG Ittner, AR Weisman, RS Agyekum… - Critical care …, 2022 - journals.lww.com
… To examine our signature’s potential use in the development of subphenotypes for …
Because weighted regression violates the assumption of heteroscedasticity, ses were estimated …

[HTML][HTML] Building effective collaborations for the study of COVID-19 across the severity spectrum

RS Agyekum, BA Abramoff, EJ Wherry, NJ Meyer - Nature Immunology, 2022 - nature.com
Translational patient-oriented research is essential for understanding the immunopathology
of SARS-CoV-2 and the varied host responses to this virus. Successful research …

[HTML][HTML] Patients' Perspectives on Life and Recovery 1 Year After COVID-19 Hospitalization

…, P Kalyani, N Smyk, AP Turner, RS Agyekum… - Journal of General …, 2023 - Springer
… And I think it’s important this neurological piece, I don’t know in a general sense who would
… a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of …

Acute Respiratory Distress Syndrome Mediates the Association between Early Plasma Soluble Receptor for Advanced Glycation End Products Concentrations and …

…, TG Dunn, AP Turner, RS Agyekum… - American Journal of …, 2023 - atsjournals.org
Reprints: No reprints will be ordered Financial Support: This work was funded by HL149851
(TKJ), HL155159 (JPR), HL140482 (BJA), HL137915 (NJM), HL15504 (NJM), HL137006 (…

Elevation of Circulating LIGHT (TNFSF14) and Interleukin-18 Levels in Sepsis-Induced Multi-Organ Injuries

…, JP Reilly, TK Jones, HM Giannini, RS Agyekum… - medRxiv, 2021 - medrxiv.org
Objective The cytokines, LIGHT (TNFSF14) and Interleukin-18 (IL-18), are two important
therapeutic targets due to their central roles in the function of activated T cells and inflammatory …

Prospective Study of Immune Phenotype and Associated Outcomes in Patients with Leukemia and Acute Respiratory Distress Syndrome

…, CAG Ittner, AP Turner, TG Dunn, RS Agyekum… - Blood, 2022 - ashpublications.org
Background: Patients with active malignancy are frequently admitted to intensive care units (ICUs)
and experience organ failure including acute respiratory distress syndrome (ARDS). …